Northland Capital Markets analyst Jason Wittes upgraded Globus Medical (NYSE: GMED) from Market Perform to Outperform with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades

Globus Medical (GMED) PT Raised to $63 at UBSAugust 6, 2020 6:55 AM Globus Medical (GMED) PT Raised to $63 at BTIGAugust 6, 2020 6:06 AM Globus Medical (GMED) PT Raised to $65 at Needham & CompanyAugust 6, 2020 5:44 AM Globus Medical (GMED) PT Raised to $58 at Credit SuisseAugust 6, 2020 5:40 AM Globus Medical (GMED) PT Raised to $64 at SVB LeerinkAugust 6, 2020 5:15 AM Globus Medical (GMED) Tops Q2 EPS by 18cAugust 5, 2020 5:13 PM Globus Medical Reports Second Quarter 2020 ResultsAugust 5, 2020 4:16 PM